Literature DB >> 3494323

Urethral trichomoniasis in men.

A S Latif, P R Mason, E Marowa.   

Abstract

Three hundred twenty-five men with confirmed urethral trichomoniasis were seen at sexually transmitted diseases clinics in Harare, Zimbabwe, in 1983-1984. The mean age of these patients was 30.4 years. The most common symptoms were urethral discharge and urethral irritation. Symptoms in 252 patients (78%) had been present for more than four weeks. Only 1.5% of 5548 patients with nontrichomonal nongonococcal urethritis had had symptoms for this length of time. In most patients with trichomoniasis (99.4%), the discharge was milky white and fluid in nature; when a smear of the discharge was made on a glass slide, small clumps of material were noted. Microscopic examination of the gram-stained smear showed relatively few polymorphonuclear leukocytes but many epithelial cells. Although Trichomonas vaginalis was readily demonstrated by microscopy of both urethral secretions and centrifuged deposits of urine, the organism was cultured only from urethral exudates. Concomitant infection with T. vaginalis was uncommon in patients with proved gonococcal urethritis. Treatment of trichomoniasis in men with a single 2-g dose of metronidazole was unsuccessful in 42.9% of cases. However, treatment with 400 mg of metronidazole thrice daily for five days gave a cure rate of 100%.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Age Factors; Antibiotics--administraction and dosage; Biology; Clinical Research; Demographic Factors; Developing Countries; Diseases; Drugs; Eastern Africa; English Speaking Africa; Examinations And Diagnoses; Infections; Laboratory Examinations And Diagnoses; Measurement; Physiology; Population; Population Characteristics; Prevalence; Reproductive Tract Infections; Research Methodology; Sexually Transmitted Diseases; Signs And Symptoms; Treatment; Urogenital Effects--men; Urogenital System; Zimbabwe

Mesh:

Substances:

Year:  1987        PMID: 3494323     DOI: 10.1097/00007435-198701000-00002

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  6 in total

1.  Trichomonas vaginalis epidemiology: parameterising and analysing a model of treatment interventions.

Authors:  F J Bowden; G P Garnett
Journal:  Sex Transm Infect       Date:  2000-08       Impact factor: 3.519

2.  Survival of Trichomonas vaginalis in human semen.

Authors:  J J Daly; J K Sherman; L Green; T L Hostetler
Journal:  Genitourin Med       Date:  1989-04

3.  Validation of a urine-based PCR-enzyme-linked immunosorbent assay for use in clinical research settings to detect Trichomonas vaginalis in men.

Authors:  S Cornelia Kaydos-Daniels; William C Miller; Irving Hoffman; Topia Banda; Willard Dzinyemba; Francis Martinson; Myron S Cohen; Marcia M Hobbs
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

Review 4.  Trichomonas vaginalis screening and prevention in order to impact the HIV pandemic: Isn't it time we take this infection seriously?

Authors:  Gweneth B Lazenby
Journal:  Infect Dis Rep       Date:  2011-04-11

Review 5.  Recent advances in the epidemiology, diagnosis, and management of Trichomonas vaginalis infection.

Authors:  Olivia T Van Gerwen; Christina A Muzny
Journal:  F1000Res       Date:  2019-09-20

6.  IL-6 produced by prostate epithelial cells stimulated with Trichomonas vaginalis promotes proliferation of prostate cancer cells by inducing M2 polarization of THP-1-derived macrophages.

Authors:  Ik-Hwan Han; Hyun-Ouk Song; Jae-Sook Ryu
Journal:  PLoS Negl Trop Dis       Date:  2020-03-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.